CCC Intelligent Solutions (CCC) Q2 2026 earnings review

Solid Execution, But Growth Dips Below Double Digits

CCC Intelligent Solutions posted a solid Q2 2026, beating expectations and raising full-year guidance, but the top-line trajectory is cooling. Revenue grew 9.8% YoY to $285.9M, breaking a multi-quarter streak of 12-13% growth. Profitability remains robust with a 40% Adjusted EBITDA margin ($115.5M), though it dipped sequentially, reflecting planned expense phasing. The highlight is commercial momentum: multiple top-five insurers expanded AI deployments from pilot to production. While the AI transition is real, the cost of innovation is weighing on adjusted gross margins, which contracted 200 bps YoY to 76%.

๐Ÿ‚ Bull Case

AI Pilots Maturing into Production

Two top-five carriers expanded AI claims routing, and another top-five carrier became the largest adopter of the AI subrogation solution. This validates the ROI of CCC's platform and de-risks long-term adoption.

Free Cash Flow Surges

Free cash flow for the quarter jumped dramatically to $82.4 million from $27.4 million a year ago, proving the cash-generative power of the 85% subscription-based model.

๐Ÿป Bear Case

Top-Line Deceleration

After quarters of 12%+ growth, revenue growth decelerated to 9.8% in Q2. Q3 guidance implies further deceleration to ~8.8% YoY, indicating that AI upsells are not fully offsetting macro claim volume headwinds or contract true-ups from prior periods.

Gross Margin Compression

Adjusted gross margin fell to 76% from 78% a year ago. As previously noted by management, deploying new AI modules carries heavy initial depreciation and support costs, diluting margins before volume scales.

โš–๏ธ Verdict: โšช

Neutral to Bullish. Execution is highly consistent and cash generation is excellent. However, investors need to monitor the slowing growth rate and whether the expanding AI suite can reaccelerate the top line past 10% in upcoming quarters.

Key Themes

DRIVER NEW ๐ŸŸข

AI Workflow Operationalization at Scale

The narrative is officially shifting from 'testing AI' to 'deploying AI.' In Q2, two top-five insurers based on direct premium written expanded their adoption of CCC's AI-based claims routing. This accelerates early total-loss identification and improves repair facility utilization. This is a critical driver for driving cross-sell and upsell metrics (NDR) in the coming quarters.

DRIVER NEW ๐ŸŸข

Subrogation and Casualty Gaining Ground

A top-five carrier adopted the AI-enabled subrogation solution, becoming the largest customer to scale it under a multi-year deal. Subrogation and casualty represent a massive white-space opportunity for CCC, historically relying on manual, error-prone processes. Penetrating the top five carriers provides crucial referenceability for the rest of the market.

DRIVER โšช

Repair Facility Digitization via Mobile Jumpstart

One of the largest multi-store operators (MSOs) renewed its multi-year deal and reported using the AI-powered 'Mobile Jumpstart' to initiate 98% of its repair estimates. Two additional large MSOs expanded usage, driving double-digit increases in participating facilities. This strengthens CCC's network moats on the repair side of the ecosystem.

CONCERN ๐Ÿ”ด

Revenue Growth Trajectory Decelerating

While total revenue met expectations, the growth rate is decelerating. Following the 12% organic growth in Q1 2026 (which included a 1% benefit from true-ups), Q2 landed at 9.8%. The Q3 guide of $290.5M at the midpoint represents roughly 8.8% growth. Management must prove that emerging AI products can offset the persistent drag of lower industry claim volumes.

CONCERN ๐Ÿ”ด

Gross Margin Bearing the Cost of Innovation

Adjusted gross margin fell 200 bps year-over-year to 76%. Management has historically attributed this to the depreciation and compute costs associated with launching intensive AI solutions. While the long-term target remains 80%, investors must accept near-term margin pressure as the AI portfolio scales.

Other KPIs

Free Cash Flow (26Q2) $82.4 million

Reversing prior weakness. FCF surged from $27.4 million in Q2 2025. Operating cash flow more than doubled to $101.6 million, demonstrating the immense operating leverage of the subscription model once working capital timing normalizes.

Net Debt and Liquidity $1.15 billion net debt

Stable. The company holds $115.9 million in cash against $1.27 billion in total debt. While net leverage is substantial, the strong FCF generation adequately covers debt service while allowing for the company's ongoing share repurchase programs.

Guidance

FY26 Revenue $1.158 - $1.164 billion

Stable. The midpoint of $1.161B implies ~9.8% YoY growth versus FY25. This is a slight raise from the prior guidance of $1.155B - $1.163B, confirming that management retains excellent visibility into back-half performance.

FY26 Adjusted EBITDA $485 - $491 million

Stable. The midpoint of $488 million implies a full-year margin of ~42%. This is a $1 million bump from the Q1 guide, showing that despite near-term gross margin pressure, overall cost controls (like G&A scaling) are keeping bottom-line targets intact.

Q3 2026 Revenue $289.5 - $291.5 million

Decelerating. Implies approximately 8.8% YoY growth compared to Q3 2025. This confirms a step down from the double-digit growth rates enjoyed throughout FY25 and early FY26.

Q3 2026 Adjusted EBITDA $118 - $120 million

Accelerating sequentially. Rebounds from the $115.5M posted in Q2. Management previously telegraphed that Q2 margins would dip due to the phasing of operating expenses, with expansion resuming in the second half of the year.

Key Questions

Revenue Growth Trajectory

With Q3 guidance implying high-single-digit growth, is the transition from pilot to production for AI solutions expected to drive reacceleration back above 10% in FY27, or is ~9% the new normalized baseline?

Gross Margin Dilution

Adjusted gross margin compressed to 76% this quarter. How long will the depreciation drag from scaling new AI products persist before unit economics improve and we trend back toward the 80% long-term target?

Subrogation Deal Ramp

Regarding the top-five insurer that signed a multi-year AI subrogation deal, what is the expected timeline for this contract to hit its full revenue run rate, and does it carry volume-based true-up potential?